| Document |
Document Title |
|
WO/2021/253847A1 |
Disclosed is the use of a deprotonated phenyl bridged β-ketimine lithium compound in a hydroboration reaction. The hydroboration reaction involves using an ester and a borane as reaction substrates. In the present invention, the deproto...
|
|
WO/2021/253868A1 |
The present invention relates to a carbonate hydroboration reaction, and particularly relates to a hydroboration reaction method with a carbonate and borane as raw materials. β-ketimines, as an important class of non-metallocene ligands...
|
|
WO/2021/255319A1 |
Structurally simple organic compounds with antitumour activity by acting on mitochondria through various action mechanisms hold substantial promise for development as cancer treatment agents. The present invention relates to new compound...
|
|
WO/2021/252640A1 |
The present disclosure relates to compounds of formulas (A) and (I), pharmaceutically acceptable salts thereof, and solvates of any of the foregoing, pharmaceutical compositions comprising the same, methods of preparing the same, interme...
|
|
WO/2021/252650A1 |
Compounds which are oxadiazaborole derivatives are disclosed, including compounds of the following genus: The compounds are inhibitors of hematopoietic cell kinase (HCK) and exhibit anti-fibrotic and anti-proliferative effects. They are ...
|
|
WO/2021/244801A1 |
A metal-organic coordination compound, wherein the coordination compound comprises at least one divalent lanthanide coordinated by a cyclic organic ligand according to formula (1), wherein · i is larger than 3; and · n is equal to 1, 2...
|
|
WO/2021/245221A1 |
The invention relates to an organic molecule, in particular for the application in optoelectronic devices. According to the invention, the organic molecule has a structure of formula I.
|
|
WO/2021/244529A1 |
Provided are a radiolabeled boron-containing compound, a preparation method and an application. The radiolabeled boron-containing compound having a structure I, wherein R1 and R2 are OH or represent, together with boron atoms attached th...
|
|
WO/2021/228114A1 |
Provided are a boron-nitrogen compound as represented by formula (I), a composition comprising the compound, and an application of the compound and composition in the field of organic electroluminescence. An organic electroluminescence d...
|
|
WO/2021/230133A1 |
[Problem] To provide a novel polycyclic aromatic compound, and an organic EL element that uses the same. [Solution] A polycyclic aromatic compound represented by general formula (1A) or general formula (1B) increases options for organic ...
|
|
WO/2021/230653A1 |
The present invention relates to: an anthracene derivative compound having a specific structure; and an organic light-emitting device having low-voltage driving characteristics, comprising same, and also relates to an organic light-emitt...
|
|
WO/2021/229050A1 |
The invention relates to an organic molecule for use in optoelectronic devices. The organic molecule has a structure of formula I: wherein, Ra and R2 are independently selected from the group consisting of: hydrogen, deuterium, N(R5)2, O...
|
|
WO/2021/228776A1 |
The present invention relates to the field of fluorescent compounds and dyes. In particular, it provides the use of a polyphenol, such as quercetin or luteolin, and a diaryl borinic compound, e.g., 2-aminoethoxydiphenyl borate (also refe...
|
|
WO/2021/226675A1 |
The invention provides a zwitterionic plastic crystal (ZIPC) compound in the form of a single molecule comprising: at least one positively charged functional group carrying at least one positive charge, and at least one negatively functi...
|
|
WO/2021/223688A1 |
The present disclosure relates to an organic compound and an electronic element and electronic apparatus using same. The organic compound has a structure as shown in the following formula (I), wherein A1, A2, A3 and A4 are the same as or...
|
|
WO/2021/224368A1 |
The invention relates to an organic molecule for optoelectronic devices. According to the invention, the organic molecule has a structure of formula I: Formula I wherein T and V is independently from another selected from the group consi...
|
|
WO/2021/226423A1 |
Processes of polymerizing olefins. The process includes polymerizing contacting ethylene and a (C3-C40)alpha-olefin comonomer in the presence of a catalyst system comprising a procatalyst and a bimetallic activator complex. The bimetalli...
|
|
WO/2021/223156A1 |
Disclosed in the present invention are a diboron glycol ester, a preparation method therefor, an intermediate thereof, and an application thereof. The diboron glycol ester can be used for inducing a reduction coupling reaction in which i...
|
|
WO/2021/226114A1 |
Disclosed herein are antimicrobial compounds, polymorphic forms, compositions, pharmaceutical compositions, the method of use and preparation thereof. Some embodiments relate to boronic acid derivatives and their use as therapeutic agent...
|
|
WO/2021/221304A1 |
Provided are a compound represented by a specific chemical formula, an anti-reflective film including same, and a display device including the anti-reflective film.
|
|
WO/2021/221303A1 |
Provided are a compound represented by a specific chemical formula, an anti-reflection film comprising same, and a display device comprising the anti-reflection film.
|
|
WO/2021/222637A1 |
The present disclosure is concerned with small molecule modulators of KLF15 signaling useful for treating various disorders such as, for example, kidney disease (e.g., chronic kidney disease), heart disease, obesity, or a neurodegenerati...
|
|
WO/2021/214308A1 |
The invention relates to an organic molecule, in particular for the application in optoelectronic devices. According to the invention, the organic molecule has a plurality of units, wherein each unit comprises or consists of a structure ...
|
|
WO/2021/214310A1 |
The invention relates to an organic molecule, in particular for the application in optoelectronic devices. According to the invention, the organic molecule is represented by a plurality of units, wherein each unit comprises or consists o...
|
|
WO/2021/214306A1 |
The invention relates to an organic molecule, in particular for the application in optoelectronic devices. According to the invention, the organic molecule is represented by a plurality of units, wherein each unit comprises or consists o...
|
|
WO/2021/213972A1 |
The invention relates to an organic molecule, in particular for the application in optoelectronic devices. According to the invention, the organic molecule has a structure of formula I wherein RI, RII, RIII, RIV, RV, RVI, RVII, RVIII, RI...
|
|
WO/2021/215446A1 |
This compound is represented by general formula (1). In general formula (1), X1 is CR1 or a nitrogen atom, X2 is CR2 or a nitrogen atom, X3 is CR3 or a nitrogen atom, X4 is CR4 or a nitrogen atom, X5 is CR5 or a nitrogen atom, X6 is CR6 ...
|
|
WO/2021/213358A1 |
Provided in the present invention are boron-containing compounds as represented by formula (I) or pharmaceutically acceptable salts thereof, pharmaceutical compositions including same, and an application of serving as a selective estroge...
|
|
WO/2021/214309A1 |
The invention relates to an organic molecule, in particular for the application in optoelectronic devices. According to the invention, the organic molecule is represented by the following formula (I), wherein: n = 0 or 1; and X is at sel...
|
|
WO/2021/211741A1 |
Compounds having the structure of Formula (I) or pharmaceutically acceptable isomers, racemates, hydrates, solvates or salts thereof, where A, R1, R2a, R2b, R2c and R3 are as defined herein, are useful in the modulation of IL-12, IL-23 a...
|
|
WO/2021/210894A1 |
The present invention relates to a boron compound expressed by any one chemical formula from among chemical formulas A to E, and an organic light-emitting element comprising the boron compound, the chemical formulas A to E being as descr...
|
|
WO/2021/210501A1 |
The present invention provides a compound represented by formula (I) (wherein X, Y, and Z are each independently a hydrogen atom or an (un)substituted nitrogen-containing heteroaryl group but Y and/or Z is an (un)substituted nitrogen-con...
|
|
WO/2021/207352A1 |
Embodiments of the instant disclosure relate to novel methods and compositions for treating tumors resistant to one or more anticancer drugs, such as platinum-based chemotherapeutics.
|
|
WO/2021/204646A1 |
The present invention relates to polycyclic compounds which are suitable for use in electronic devices, and to electronic devices, in particular organic electroluminescent devices containing said compounds.
|
|
WO/2021/198509A1 |
The invention relates to a process for preparing a boronic anhydride compound of formula (1), wherein, R1 - R4 are substituents as defined in the disclosure and 'B' stands for the element boron. The invention also describes a process of ...
|
|
WO/2021/201054A1 |
This non-aqueous electrolyte for batteries contains a phosphazene compound (A) including at least one among a phosphazene compound represented by formula (1) and a phosphazene compound represented by formula (2). In formulae (1) and (2),...
|
|
WO/2021/202802A1 |
Embodiments of the present disclosure relate to sensors that can selectively bind to specific vicinal diols in the presence of other diols. These boronated vicinal diol-responsive sensor compounds can sense levels of specific vicinal dio...
|
|
WO/2021/196274A1 |
A fluorescent material and a synthesis method therefor. The fluorescent material has the following structural formula: (I), wherein Y is an N atom or a B atom; X1 and X2 are the same or different, and are selected from among a C atom or ...
|
|
WO/2021/191229A1 |
A method of identifying a target analyte in which a sample containing a light-emitting marker configured to bind to the target analyte is irradiated and emission from the light-emitting marker is detected. The light-emitting marker compr...
|
|
WO/2021/194216A1 |
A polycyclic aromatic compound or a condensed multimer thereof, according to the present invention, is employed in an organic layer in an organoelectroluminescent device, thereby enabling the implementation of an organoelectroluminescent...
|
|
WO/2021/191058A1 |
The present invention relates to compounds of the formula (1) which are suitable for use in electronic devices, in particular organic electroluminescent devices, and to electronic device.
|
|
WO/2021/189112A1 |
A method for detection of a nerve agent in a sample, which method comprises (a) irradiating an optical sensing element, the optical sensing element comprising a fluorescent sensing compound provided on a substrate, and measuring the lumi...
|
|
WO/2021/194298A1 |
The present invention relates to nanoparticles comprising drug dimers, and a use thereof. The nanoparticles comprising drug dimers, of the present invention, can increase drug content and improve the drug dispersibility. In addition, the...
|
|
WO/2021/191183A1 |
The invention relates to cyclic compounds which are suitable for use in electronic devices, and to electronic devices, in particular organic electroluminescent devices containing said compounds.
|
|
WO/2021/185829A1 |
The invention relates to heterocyclic compounds which are suitable for use in electronic devices, and to electronic devices, in particular organic electroluminescent devices, containing said compounds.
|
|
WO/2021/187939A1 |
The present invention relates to a boron compound usable in an organic light-emitting element, and an organic light-emitting element comprising same, and more specifically, to a boron compound represented by [Chemical Formula A] and an o...
|
|
WO/2021/185712A1 |
The invention relates to heteroaromatic compounds which are suitable for use in electronic devices, and to electronic devices, in particular organic electroluminescent devices, containing said compounds.
|
|
WO/2021/188700A1 |
Disclosed herein are antimicrobial compounds, polymorphic forms, compositions, pharmaceutical compositions, the method of use and preparation thereof. Some embodiments relate to boronic acid derivatives and their use as therapeutic agent...
|
|
WO/2021/187868A1 |
Disclosed are a compound, a photosensitizer comprising same, a composition for diagnosing or treating a tumor targeting mitochondria, and a photodynamic treatment method using the composition. The compound may be represented by the above...
|
|
WO/2021/187507A1 |
The compound represented by the general formula has excellent light-emitting characteristics and emits light having a short wavelength. Y1 is N-RA; Y2 is O, S, C=O or N-RA; RA is an aryl group, etc.; R1-R11 are hydrogen atoms or substitu...
|
